Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_04727 |
| Species: | Homo sapiens |
| Position : | chr2:60495216-60495315 |
| Year: | 2021 |
| Title: | Multiplex CRISPR/Cas9 genome editing in hematopoietic stem cells for fetal hemoglobin reinduction generates chromosomal translocations. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 34853798 |
| Tissue: | bone marrow |
| Tissue Ontology ID: | UBERON:0002371 |
| Cell Source: | CD34+ hematopoietic stem cells |
| Cell Type: | CD34-positive hematopoietic stem cell |
| Experiment Type: | Functional perturbation assay |
| High Throughput Method: | RNA-seq |
| Low Throughput Method: | CRISPR Knockout; RT-RT-qPCR; HPLC; Flow cytometry; CRISPR-Cas9 |
| Target gene : | BCL11A |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|